Patent · US Active

ASC as a marker for lung cancer

US10175241B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Herbert Andres · Penzberg, DE
Marie-Luise Hagmann · Penzberg, DE
Johann Karl · Peißenberg, DE
Markus Roessler · Germering, DE
Michael Tacke · Munich, DE

Key dates

Filing date	Dec 15, 2010
Grant date	Jan 8, 2019
Priority date	—
Expiry date	Aug 19, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/4742
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to the assessment of lung cancer. It discloses the use of protein ASC in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring ASC in the sample. Measurement of ASC can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.